The efficacy of continuous consumption of CH-3 (milk origin peptide) for cognitive function: A pilot study

The efficacy of continuous consumption of CH-3 (milk origin peptide) for cognitive function: A pilot study - A pilot study for "Flat Care"

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016084

Enrollment

Registered

2014-12-29

Start date

2013-10-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nothing

Interventions

In peptide group, participants take a pill of tablet including 500mg CH-3 peptide once a day for 4 months. In control group, they don&#39

t receive the CH-3 tablet, and live with their usual lifestyles for 4 months.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1)The residents of Niihama city, Ehime (2)Those whose age at the time of informed consent is 60 and over. (3)Those who can understand the purpose and the contents of this study, and can agree with participation by letter.

Exclusion criteria

Exclusion criteria: (1)The presence of allergic response to milk product. (2)In addition, those who were judged inadequate by investigator.

Design outcomes

Primary

Measure	Time frame
Score of MMSE (Mini-Mental State Examination)	—

Secondary

Measure	Time frame
Blood pressure	—

Countries

Japan

Contacts

Public ContactTetsu Kinoshita

Community Life Sciences Co., Ltd. Social Epidemiology Institute

tetsu.prospective@gmail.com089-904-7811

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026